SMSPHARMA.NSSMSPHARMA.NSNSE

Revenue (LTM)

$7.8B

+10.4% YoY

Net Income (LTM)

$691M

+38.8% YoY

Free Cash Flow

$-589M

Revenue CAGR (5Y)

+14.0%

Marginsdeclining

FCF($0.6B)

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	5,608	5,150↓8.2%	5,221↑1.4%	7,093↑35.9%	7,827↑10.4%
Gross Profit	1,814	1,814↑0.0%	1,289↓28.9%	2,109↑63.6%	1,449↓31.3%
Operating Income	977	790↓19.1%	213↓73.0%	1,340↑528.0%	1,033↓22.9%
Net Income	625	622↓0.5%	-71↓111.3%	498↑805.8%	691↑38.8%
EBITDA	1,246	1,195↓4.0%	594↓50.3%	1,175↑97.9%	1,452↑23.6%
EPS Diluted	7.39	7.35↓0.5%	-0.83↓111.3%	5.89↑809.6%	8.15↑38.4%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	404	466↑15.2%	74↓84.2%	360↑388.5%	416↑15.4%
Total Current Assets	3,093	3,771↑21.9%	4,106↑8.9%	5,339↑30.0%	5,545↑3.9%
Total Assets	8,122	8,595↑5.8%	8,796↑2.3%	10,341↑17.6%	11,527↑11.5%
Total Current Liabilities	1,954	1,965↑0.5%	2,549↑29.7%	3,317↑30.1%	3,244↓2.2%
Total Liabilities	4,017	3,892↓3.1%	4,191↑7.7%	4,978↑18.8%	5,130↑3.1%
Total Equity	4,105	4,703↑14.6%	4,605↓2.1%	5,363↑16.5%	6,396↑19.3%
Total Debt	2,546	2,633↑3.4%	2,541↓3.5%	2,808↑10.5%	3,108↑10.7%
Net Debt	2,142	2,167↑1.2%	2,467↑13.8%	2,447↓0.8%	2,692↑10.0%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	905	402↓55.5%	225↓44.2%	501↑123.3%	645↑28.7%
Capital Expenditure	-1,517	-272↑82.0%	-299↓9.8%	-522↓74.3%	-1,234↓136.5%
Free Cash Flow	-613	130↑121.2%	-75↓157.5%	-20↑72.8%	-589↓2791.8%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	309	62↓80.1%	-392↓736.5%	287↑173.3%	54↓81.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance